% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Ceccon:872973,
author = {Ceccon, Garry and Wollring, Michael and Brunn, Anna and
Deckert, Martina and Waldschmidt, Dirk and Fink, Gereon R.
and Galldiks, Norbert},
title = {{L}eptomeningeal {C}arcinomatosis in a {P}atient with
{P}ancreatic {C}ancer {R}esponding to {N}ab-{P}aclitaxel
plus {G}emcitabine},
journal = {Case reports in oncology},
volume = {13},
issn = {1662-6575},
address = {Basel},
publisher = {Karger},
reportid = {FZJ-2020-00430},
pages = {35 - 42},
year = {2020},
abstract = {Leptomeningeal carcinomatosis is an extremely rare, but
devastating complication in pancreatic cancer patients with
a poor prognosis despite multimodal treatment. We present a
51-year-old male patient with the very rare condition of
leptomeningeal carcinomatosis originating from pancreatic
cancer. He presented to our hospital with severe headache
and neck stiffness 30 months after systemic chemotherapy.
Cerebral and spinal MRI as well as cerebrospinal fluid
examination confirmed the diagnosis of leptomeningeal
carcinomatosis. The patient responded to gemcitabine plus
nab-paclitaxel in terms of elimination of tumor cells from
the CSF and concurrent clinical improvement for 3 months.
The observed findings suggest that the combination of
gemcitabine plus nab-paclitaxel is potentially effective in
affected cerebrospinal fluid of pancreatic carcinoma
patients.},
cin = {INM-3},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406},
pnm = {572 - (Dys-)function and Plasticity (POF3-572)},
pid = {G:(DE-HGF)POF3-572},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32095126},
UT = {WOS:000533875000007},
doi = {10.1159/000504697},
url = {https://juser.fz-juelich.de/record/872973},
}